Progenics Pharmaceuticals Inc. (PGNX) fell -5.09% or -0.33 to $6.16. It is nearly 1.18 million shares traded, which is 85.58% compare to the average total volume 1.38 million. The market cap of PGNX is $432.86 million. The year to date change is 5.53%. The 52 week price range is from $4.6 to $11.72. Price of PGNX have changed -1.22% during last week. It have changed 9.08% over last month, 6.22% over last 3 months, 7.63% over last 6 months and -22.00% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PGNX is 5.93. It is -3.73% below current price. The 200-day Moving Averages for PGNX is 6.53. It is 6.01% above current price. The 52-week High is 11.72. It is 90.26% from the current price. The 52-week Low is 4.6. It is -25.32% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of PGNX is 4.46 on 2018-01-12. Short % to float is 10.59%. There are some statistics of PGNX. It is has market cap $432.86 million. The share outstanding is 70.27 million. The average volume is 1.38 million. The revenue is 12.46M. It has 477.45M cash and 99.19M in debt. The percent of top 15 Institution holding is 75.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PGNX is -63.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PGNX is -35.07%.